Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose atropine for pediatric myopia progression and accommodative function
ChiCTR2500101777Phase 4Not yet recruiting
- Sponsor
- Hebei Eye Hospital
- Start
- Apr 2025
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atropine in myopia (2 arms), sponsored by Hebei Eye Hospital. Primary endpoint: Correlation between 12-month changes in accommodative system parameters and changes in equivalent spherical refraction and axial length. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2500101777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101777.